Chiaro, Jacopo (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/jacopo-chiaro-9380405
Datta, Subhamoy (2025-)
https://researchportal.helsinki.fi/en/persons/subhamoy-datta
Filppu, Pauliina (2025-)
Pauliina Filppu earned her PhD in translational cancer research from the University of Helsinki in 2022 under the supervision of prof. Pirjo Laakkonen. She is currently working as a postdoctoral researcher, investigating the complex role of the tumor microenvironment in brain tumor progression and therapy resistance. She combines experimental approaches with computational tools to understand how interactions between tumor cells, stromal cells, and immune cells shape disease outcomes.
https://www.helsinki.fi/en/researchgroups/tumor-progression-and-metastasis
Cheng, Ruoyu (2025-)
Ruoyu Cheng completed her PhD in February 2023, with a joint degree from the University of Helsinki and the University of Groningen under the supervision of Prof. Helder Santos. She is an expert on nanomedicine for cancer immunotherapy. Currently, she is a postdoctoral researcher focusing on engineering cytotoxic T cells with nanomedicine for cancer immunotherapy. https://www.helsinki.fi/en/researchgroups/intracellular-drug-delivery/people
Gojkovic, Milos (2025-)
https://researchportal.helsinki.fi/en/persons/milos-gojkovic
Imlimthan, Surachet (2025-)
Surachet (Oxy) is originally from Bangkok, Thailand, and is a radiopharmaceutical scientist with international training in bioengineering and radiochemistry. His work focuses on the design of small molecules and advanced drug-delivery nanosystems, including theranostic platforms from naturally derived materials and the translation of radiotracers—such as FAP-targeting agents—into preclinical cancer models. He is also involved in boron neutron capture therapy (BNCT) research, developing and evaluating next-generation boron delivery systems for targeted cancer treatment. He is currently based at the TRIM Group. His expertise covers chemical synthesis, radiochemistry, and multidisciplinary preclinical evaluation.
Jha Sweta (2025-)
Sweta Jha earned her Ph.D. in Biochemistry and Developmental Biology from the University of Helsinki in 2024 under the supervision of Docent Carina Holmberg. She is currently working as a postdoctoral researcher in Professor Liisa Kauppi’s laboratory, where her research is focused on elucidating the molecular mechanisms underlying chemotherapy-induced chronic DNA damage response in high-grade serous ovarian cancer. She possesses extensive expertise in live-cell imaging, confocal and widefield microscopy, biochemical assays, and quantitative image analysis.
Kremneva, Elena (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/elena-kremneva-9103624
Kuusela, Sara (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/sara-kuusela-9091328
Laury, Anna (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/anna-laury-9394129
Liaqat, Inam (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/inam-liaqat-9377221
Mäkelä, Otto (2025-)
https://researchportal.helsinki.fi/fi/persons/otto-m%C3%A4kel%C3%A4
Malaymar Pinar, Dicle (2025-)
https://researchportal.helsinki.fi/en/persons/dicle-malaymar-pinar
Marin Falco, Matias (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/matias-marin-falco-9421781
Miihkinen, Mitro (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/mitro-miihkinen-9358095
Natalie Ap. Rodrigues Fernandes (2025-)
Natalie is a postdoctoral researcher in the Head and Neck Cancer Immunology Group, Al-Samadi Lab, where her work focuses on investigating monocyte modulation in oral cancer. She has 10 years of experience working with monocyte/macrophage biology in oral diseases, using both in vitro and in vivo models. Natalie earned her PhD in Dentistry with a focus on Biosciences in 2024 at São Paulo State University (UNESP), Brazil. During her doctoral studies, she completed a one-year research visit at the University of Helsinki in Tuula Salo’s group. Her PhD research focused on the role of the tumor microenvironment in oral cancer, with particular emphasis on cancer-associated fibroblasts, fibronectin, and monocytes.
https://researchportal.helsinki.fi/en/persons/natalie-aparecida-rodrigues-fernandes
Munne, Pauliina (2025-)
https://researchportal.helsinki.fi/fi/persons/pauliina-munne
Karita Peltonen (2025-)
Karita received her Ph.D. in the field of cancer biology at University of Helsinki and continued her post-doctoral training at the Drug Research Program, University of Helsinki specializing in tumor antigen discovery. Her current research at Hematology Research Unit Helsinki aims for better understanding on how tumor immune microenvironment and tumor cell-intrinsic factors influence tumor immunity and immunotherapy responses. She is especially interested in antigen-specific T-cell responses.
https://www.helsinki.fi/en/researchgroups/hematology-research-unit-helsinki
Pink, Anne (2025-)
Rajamäki, Kristiina (2025-)
Kristiina Rajamäki received her PhD in Biochemistry in 2016 (Wihuri Research Institute and University of Helsinki (UH)). After a postdoctoral period at Helsinki Rheumatic Diseases and Inflammation Research Group (UH), she has continued as a researcher in Prof. Lauri Aaltonen’s Tumor Genomics Group (UH). Her work focuses on colorectal cancer and uterine leiomyoma, utilizing various high-throughput sequencing technologies to characterize clinical tumour samples and CRISPR-engineered cell lines.
Seref Vujaklija, Ceren (2025-)
https://www.helsinki.fi/fi/tutustu-meihin/ihmiset/henkilohaku/ceren-seref-vujaklija-9443045
Sever, Tolga (2025-)
Seyednasrollah, Fatemeh (2025-)
https://researchportal.helsinki.fi/fi/persons/niko-v%C3%A4lim%C3%A4ki/
Sinervuori, Ella (2025-)
https://www.helsinki.fi/en/about-us/people/people-finder/ella-sinervuori-9359330: iCANPOD members
Välimäki, Niko (2025-)
Niko Välimäki received his Ph.D. in computer science from the University of Helsinki in 2012. Since then he has continued as a researcher in prof. Lauri A. Aaltonen’s tumor genomics group. Niko’s work involves bioinformatics and computational data analysis of the various high-throughput data. His current interests are in statistical inference and data science. Niko is the main iCANPOD mentor for using the iCAN Discovery platform.
https://researchportal.helsinki.fi/fi/persons/niko-v%C3%A4lim%C3%A4ki/